Literature DB >> 11510933

Medullomyoblastoma: case report.

Z F Cheema1, T C Cannon, R Leech, J Brennan, A Adesina, R A Brumback.   

Abstract

This 7-year-old boy presented with a 2-week history of headache, nausea, vomiting, anorexia, lethargy, and unsteadiness of gait. Brain magnetic resonance imaging (MRI) revealed a cystic mass within the vermis of the cerebellum. A suboccipital craniectomy was performed to remove a tumor that contained primitive neuroectodermal cells with florid skeletal muscle differentiation. Immunohistochemical studies and electron microscopy confirmed the presence of both a primitive neuroectodermal component and rhabdomyoblastic differentiation, consistent with the diagnosis of medullomyoblastoma. This exceedingly rare tumor of the cerebellar vermis of children is characterized by two components: primitive neuroectodermal tumor cells and skeletal muscle. Although the histogenesis remains uncertain, advances in immunohistochemistry and electron microscopy suggest the origin of this tumor from a multipotential stem cell precursor.

Entities:  

Mesh:

Year:  2001        PMID: 11510933     DOI: 10.1177/088307380101600812

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

1.  MyoD is a tumor suppressor gene in medulloblastoma.

Authors:  Joyoti Dey; Adrian M Dubuc; Kyle D Pedro; Derek Thirstrup; Brig Mecham; Paul A Northcott; Xiaochong Wu; David Shih; Stephen J Tapscott; Michael LeBlanc; Michael D Taylor; James M Olson
Journal:  Cancer Res       Date:  2013-10-03       Impact factor: 12.701

2.  CXCL12 sensitizes vago-vagal reflex neurons in the dorsal medulla.

Authors:  Richard C Rogers; Edouard Viard; Gerlinda E Hermann
Journal:  Brain Res       Date:  2012-11-23       Impact factor: 3.252

3.  The role of immunohistochemistry in medullomyoblastoma--a case series highlighting divergent differentiation.

Authors:  Man Updesh S Sachdeva; Mahesha Vankalakunti; Aruna Rangan; Bishan D Radotra; Rajesh Chhabra; Rakesh K Vasishta
Journal:  Diagn Pathol       Date:  2008-04-25       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.